These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1798816)

  • 1. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates.
    Leake A; Fairbairn AF; McKeith IG; Ferrier IN
    Psychiatry Res; 1991 Nov; 39(2):155-65. PubMed ID: 1798816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetrical hemispheric distribution of 3H-paroxetine binding sites in postmortem human brain from controls and suicides.
    Lawrence KM; De Paermentier F; Cheetham SC; Crompton MR; Katona CL; Horton RW
    Biol Psychiatry; 1990 Sep; 28(6):544-6. PubMed ID: 2145984
    [No Abstract]   [Full Text] [Related]  

  • 3. Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1991 May; 29(10):1016-22. PubMed ID: 1648414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5HT2 receptor changes in major depression.
    Yates M; Leake A; Candy JM; Fairbairn AF; McKeith IG; Ferrier IN
    Biol Psychiatry; 1990 Mar; 27(5):489-96. PubMed ID: 2310804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder.
    Dean B; Scarr E; Pavey G; Copolov D
    J Affect Disord; 2003 Jun; 75(1):65-9. PubMed ID: 12781352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in monoamine receptors in the brain of suicide victims.
    Arango V; Underwood MD; Mann JJ
    J Clin Psychopharmacol; 1992 Apr; 12(2 Suppl):8S-12S. PubMed ID: 1315808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls.
    Lowther S; De Paermentier F; Cheetham SC; Crompton MR; Katona CL; Horton RW
    J Affect Disord; 1997 Feb; 42(2-3):199-207. PubMed ID: 9105961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
    Guilarte TR; Hammoud DA; McGlothan JL; Caffo BS; Foss CA; Kozikowski AP; Pomper MG
    Schizophr Res; 2008 Feb; 99(1-3):324-32. PubMed ID: 18191545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain GABAB binding sites in depressed suicide victims.
    Cross JA; Cheetham SC; Crompton MR; Katona CL; Horton RW
    Psychiatry Res; 1988 Nov; 26(2):119-29. PubMed ID: 2853398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Iodotomoxetine: a novel ligand for serotonin uptake sites.
    Kung MP; Chumpradit S; Billings J; Kung H
    Life Sci; 1992; 51(2):95-106. PubMed ID: 1614281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder.
    Gray L; Scarr E; Dean B
    Psychiatry Res; 2006 Aug; 143(2-3):111-20. PubMed ID: 16831468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT receptor binding in post-mortem brain from patients with affective disorder.
    McKeith IG; Marshall EF; Ferrier IN; Armstrong MM; Kennedy WN; Perry RH; Perry EK; Eccleston D
    J Affect Disord; 1987; 13(1):67-74. PubMed ID: 2959702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.
    Sargent PA; Kjaer KH; Bench CJ; Rabiner EA; Messa C; Meyer J; Gunn RN; Grasby PM; Cowen PJ
    Arch Gen Psychiatry; 2000 Feb; 57(2):174-80. PubMed ID: 10665620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalographic frontal asymmetry and depressive symptoms in the elderly.
    Deslandes AC; de Moraes H; Pompeu FA; Ribeiro P; Cagy M; Capitão C; Alves H; Piedade RA; Laks J
    Biol Psychol; 2008 Dec; 79(3):317-22. PubMed ID: 18761052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT imaging of serotonin2 receptors in depression.
    D'haenen H; Bossuyt A; Mertens J; Bossuyt-Piron C; Gijsemans M; Kaufman L
    Psychiatry Res; 1992 Dec; 45(4):227-37. PubMed ID: 1292040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects.
    Friedman E; Wang HY
    J Neurochem; 1996 Sep; 67(3):1145-52. PubMed ID: 8752121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
    Shapiro J; Belmaker RH; Biegon A; Seker A; Agam G
    J Neural Transm (Vienna); 2000; 107(5):603-7. PubMed ID: 11072754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.